Jim Simons's position in Harvard Bioscience is currently worth $2.95 Million. That's 0.00% of their equity portfolio (1591st largest holding). The investor owns 1.56% of the outstanding Harvard Bioscience stock. The first Harvard Bioscience trade was made in Q2 2013. Since then Jim Simons bought shares 22 more times and sold shares on twenty occasions. The stake costed the investor $2.73 Million, netting the investor a gain of 7.9% so far.